UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Feeding the gut microbiome: impact on multiple sclerosis

Frontiers in immunology, 2023-05, Vol.14, p.1176016-1176016

2023

Volltextzugriff (PDF)

Eye Movement Abnormalities in Multiple Sclerosis: Pathogenesis, Modeling, and Treatment

Frontiers in neurology, 2018-02, Vol.9, p.31-31

2018

Volltextzugriff (PDF)

Lower Multiple Sclerosis Severity Score Is Associated with Higher Adherence to Mediterranean Diet in Subjects with Multiple Sclerosis from Northwestern Italy

Nutrients, 2024-03, Vol.16 (6), p.880

2024

Volltextzugriff (PDF)

Long-lasting neutralizing antibodies and T cell response after the third dose of mRNA anti-SARS-CoV-2 vaccine in multiple sclerosis

Frontiers in immunology, 2023-06, Vol.14, p.1205879-1205879

2023

Volltextzugriff (PDF)

Source of medical information and behavioral seeking patterns in patients affected with Friedreich’s ataxia and their caregivers: a survey study

Neurological sciences, 2022-05, Vol.43 (5), p.3223-3229

2022

Volltextzugriff (PDF)

Atypical Multiple Sclerosis Lesions or Progressive Multifocal Leukoencephalopathy Lesions: That Is the Question

JIM - high impact case reports, 2020, Vol.8, p.2324709620939802

2020

Volltextzugriff (PDF)

Viability and fertility of cooled equine semen diluted with skimmed milk or glycine egg yolk-based extenders

Revista brasileira de zootecnia, 2012-12, Vol.41 (12), p.2411-2417

2012

Volltextzugriff (PDF)

Ceftriaxone has a therapeutic role in Alexander disease

Progress in neuro-psychopharmacology & biological psychiatry, 2010-03, Vol.34 (2), p.416-417

2010

Volltextzugriff (PDF)

Waxing and waning ataxia

Journal of the neurological sciences, 2021-10, Vol.429, p.119557, Article 119557

2021

Volltextzugriff (PDF)

Impact of calcitonin gene-related peptide receptor antagonist on quality of life

Journal of the neurological sciences, 2021-10, Vol.429, p.119303, Article 119303

2021

Volltextzugriff (PDF)

Humoral response after the booster dose of anti-SARS-CoV-2 vaccine in multiple sclerosis patients treated with high-efficacy therapies

Multiple sclerosis and related disorders, 2022-05, Vol.61, p.103776-103776, Article 103776

2022

Volltextzugriff (PDF)

Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study

Journal of neurology, neurosurgery and psychiatry, 2020-09, Vol.91 (9), p.914-920

2020

Volltextzugriff (PDF)

High risk PML patients switching from natalizumab to alemtuzumab (P2.407)

Neurology, 2017-04, Vol.88 (16_supplement)

2017

Volltextzugriff (PDF)

"Computerized posturography is more sensitive than clinical Romberg Test in detecting postural control impairment in minimally impaired Multiple Sclerosis patients"

Multiple sclerosis and related disorders, 2017-05, Vol.14, p.51-55

2017

Volltextzugriff (PDF)

High-Risk PML Patients Switching from Natalizumab to Alemtuzumab: an Observational Study

Neurology and therapy, 2017-06, Vol.6 (1), p.145-152

2017

Volltextzugriff (PDF)

Measuring Transmission Delay Due To Demyelination in INO (P2.285)

Neurology, 2014-04, Vol.82 (10_supplement)

2014

Volltextzugriff (PDF)

A Low Percentage of CD4+ Cells Can Predict Disease Reactivation after Natalizumab Discontinuation (P2.063)

Neurology, 2016-04, Vol.86 (16_supplement)

2016

Volltextzugriff (PDF)

Long-term Effectiveness of 9-δ-tetrahydrocannabinol:Cannabidiol Oromucosal Spray in Clinical Practice: results from a 18-months Multicenter Italian Study (P5.2-085)

Neurology, 2019-04, Vol.92 (15_supplement)

2019

Volltextzugriff (PDF)

Fingolimod is Not Able to Inhibit Multiple Sclerosis Disease Reactivation after Natalizumab Discontinuation (P7.206)

Neurology, 2014-04, Vol.82 (10_supplement)

2014

Volltextzugriff (PDF)

Diagnosing disconjugate eye movements: phase-plane analysis of horizontal saccades

Neurology, 2008-10, Vol.71 (15), p.1167-1175

2008

Volltextzugriff (PDF)

D-dimer Increasing After First Alemtuzumab Administration in a Multiple Sclerosis Patient

International Journal of Clinical and Experimental Medical Sciences, 2019, Vol.5 (5), p.67

2019

Volltextzugriff (PDF)

Ceftriaxone has a therapeutic role in Alexander disease

Progress in neuro-psychopharmacology & biological psychiatry, 2010, Vol.34 (2), p.416-417

2010

Volltextzugriff (PDF)

Innate immune receptors over expression correlate with chronic chagasic cardiomyopathy and digestive damage in patients

PLoS neglected tropical diseases, 2018-07, Vol.12 (7), p.e0006589-e0006589

2018

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(54)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Feeding the gut microbiome: impact on multiple sclerosis

Eye Movement Abnormalities in Multiple Sclerosis: Pathogenesis, Modeling, and Treatment

Lower Multiple Sclerosis Severity Score Is Associated with Higher Adherence to Mediterranean Diet in Subjects with Multiple Sclerosis from Northwestern Italy

Long-lasting neutralizing antibodies and T cell response after the third dose of mRNA anti-SARS-CoV-2 vaccine in multiple sclerosis

Source of medical information and behavioral seeking patterns in patients affected with Friedreich’s ataxia and their caregivers: a survey study

Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study

Atypical Multiple Sclerosis Lesions or Progressive Multifocal Leukoencephalopathy Lesions: That Is the Question

Viability and fertility of cooled equine semen diluted with skimmed milk or glycine egg yolk-based extenders

Ceftriaxone has a therapeutic role in Alexander disease

Waxing and waning ataxia

Impact of calcitonin gene-related peptide receptor antagonist on quality of life

Humoral response after the booster dose of anti-SARS-CoV-2 vaccine in multiple sclerosis patients treated with high-efficacy therapies

Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study

High risk PML patients switching from natalizumab to alemtuzumab (P2.407)

"Computerized posturography is more sensitive than clinical Romberg Test in detecting postural control impairment in minimally impaired Multiple Sclerosis patients"

Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study)

High-Risk PML Patients Switching from Natalizumab to Alemtuzumab: an Observational Study

Measuring Transmission Delay Due To Demyelination in INO (P2.285)

A Low Percentage of CD4+ Cells Can Predict Disease Reactivation after Natalizumab Discontinuation (P2.063)

Long-term Effectiveness of 9-δ-tetrahydrocannabinol:Cannabidiol Oromucosal Spray in Clinical Practice: results from a 18-months Multicenter Italian Study (P5.2-085)

Fingolimod is Not Able to Inhibit Multiple Sclerosis Disease Reactivation after Natalizumab Discontinuation (P7.206)

Diagnosing disconjugate eye movements: phase-plane analysis of horizontal saccades

D-dimer Increasing After First Alemtuzumab Administration in a Multiple Sclerosis Patient

Ceftriaxone has a therapeutic role in Alexander disease

Innate immune receptors over expression correlate with chronic chagasic cardiomyopathy and digestive damage in patients

Aktive Filter

Suchergebnisse filtern